Antimicrobial resistance is a major threat to global health
Antibiotics are one of the most effective drugs for treating bacterial infections. But overprescription and misuse increase the risk of antimicrobial resistance (AMR), a phenomenon that occurs when bacteria like S. pneumoniae and H. influenzae develop resistance to the very drugs that were designed to neutralise them. Simply put, AMR reduces the effectiveness of antibiotics to fight respiratory infections and other life-threatening diseases.
By 2050, antimicrobial resistance (AMR) could lead to over 10 million deaths each year*
To prevent antibiotics from becoming ineffective against infectious diseases, doctors must change their approach towards on-the-ground prescription practices.
Without the right updated information, even trusted antibiotics may be ineffective at treating infections
While doctors are aware of the risk of AMR, complex data sources and short consultation times are impeding their ability to properly diagnose patients and administer the right antibiotic prescriptions. Meanwhile, most pharmaceutical companies would rather promote their own products instead of solving the problem.
Unless urgent action is taken to drive behaviour change, antibiotic resistance remains a serious threat to public health even if new medicines are developed.
*December 2014. Antimicrobial Resistance: Tackling a crisis for the health and wealth of nations https://amr-review.org
How can GSK, a global biopharmaceutical company, help doctors prevent antibiotic resistance while boosting patient recovery?
Introducing the Infection Index
A trend monitor that helps doctors stay ahead of infections and dispense effective prescriptions
Developed as a mobile application, the Infection Index uses nationwide data sources to deliver real-time updates on susceptibility of pathogens. This means doctors can make informed decisions around antibiotics while preventing overprescription.
Real-time data updates on the susceptibility of pathogens
Real-time analysis from three key data sources powers a dynamic trend monitor mapping out pathogen and AMR incidence. Through regular push notifications, doctors are promptly alerted to local antibiotic prescriptions and susceptibility trends.
Access the latest data in mere seconds
To ensure vital information is easy to access and quick to assimilate, the Infection Index summarises comprehensive guidelines and recommendations in one convenient platform.
By utilising Infection Index, doctors around the world can join the fight against AMR, while ensuring their patients get tailored prescriptions that best address their specific needs.
Bringing actionable advice to every healthcare professional
First launched in India in January 2023, Infection Index has received a series of continuous enhancements, with the next upgrade slated for December 2023. To accelerate adoption, GSK promoted the app to their pool of healthcare practitioners (HCPs) through owned media.
“Sharing up-to-date data on country/region-specific antibiotic resistance levels is critical, as it can help the development of local antibiotic prescribing guidelines and promote positive change. It can also support the roll-out of local vaccination programmes and other alternative preventative healthcare schemes, to reduce our dependency on antibiotics.”
— Dr Didem Torumkuney
Scientific Director, Infectious Diseases, GSK
Now, healthcare professionals everywhere can prevent antimicrobial resistance while improving patient outcomes.
